Skip to main content
RQIA registered healthcare provider
Clinician-led weight management

Medical weight loss, built around your health.

A structured programme combining Wegovy or Mounjaro where clinically appropriate with medical review, ongoing support and practical lifestyle change.

UK clinician review Weekly treatment Ongoing aftercare
A clinician reviewing a personalised weight management plan with a patient
More than a prescription

Medication works best as part of a programme.

The aim is safer, sustainable progress with the clinical oversight to know when to continue, adjust or stop.

Clinical assessment

Your health history, current medicines, goals and eligibility are reviewed before treatment is considered.

Prescription medication

Wegovy or Mounjaro may be prescribed when a UK clinician decides it is safe and appropriate for you.

Ongoing monitoring

Progress, tolerability and side effects are reviewed as your dose and treatment plan develop.

Lifestyle support

Medication is used alongside nutrition, activity and behaviour changes designed for long-term health.

Medication options

Wegovy and Mounjaro, explained clearly.

Both are prescription-only, once-weekly treatments. A clinician—not a preference quiz—decides whether either is suitable.

Semaglutide

Wegovy®

A GLP-1 medicine that acts on appetite pathways, helping you feel fuller and less hungry. Treatment starts at a lower dose and is adjusted gradually when appropriate.

  • Once-weekly injection
  • Used alongside diet and activity
  • Dose increased under clinical guidance
Tirzepatide

Mounjaro®

A dual GIP and GLP-1 medicine that acts on appetite and blood-sugar pathways. It is also started at a low dose and increased gradually when clinically appropriate.

  • Once-weekly injection
  • Used alongside diet and activity
  • Important contraception advice applies
Never use someone else’s medicine, buy from an unregulated seller, change dose yourself or switch between treatments without speaking to your prescriber.
Eligibility and safety

Suitability is a clinical decision.

A BMI calculation can be a useful starting point, but it cannot identify contraindications, medicine interactions or the treatment most appropriate for you.

Ask about eligibility

Weight and health criteria

Eligibility considers BMI and weight-related conditions, not appearance or a short-term target.

Current medicines

Diabetes medicines and other treatments may need closer review or adjustment.

Medical history

Digestive, pancreatic, gallbladder and other relevant health history must be considered.

Pregnancy and procedures

Pregnancy plans, contraception, breastfeeding and upcoming surgery all require specific advice.

Choose your support

A programme matched to how much support you want.

Medication and pricing vary by dose and clinical assessment. Contact our team for current programme information and the most appropriate next step.

Core

Medication with clinical oversight

For suitable patients who want the essential prescribing, pharmacy and support pathway.

  • Clinical eligibility review
  • Prescription medication if approved
  • Refrigerated tracked delivery
  • Patient support access
Enquire about pricing
More clinical insight

Plus

Metabolic bloods and clinician review

Adds a more detailed health baseline and medical interpretation to the Core pathway.

  • Everything in Core
  • In-clinic blood collection
  • Metabolic blood profile
  • Doctor-led results review
Enquire about pricing

Pro

Clinical and dietitian support

The most structured option, combining medical oversight with individual nutrition support.

  • Everything in Plus
  • Dietitian video consultation
  • Tailored nutrition strategy
  • Behaviour and habit coaching
Enquire about pricing
How it works

A safer route from interest to treatment.

01

Check eligibility

Complete a confidential online assessment covering your health, medicines and weight history.

02

Clinical review

A UK clinician reviews your information and decides whether treatment is appropriate.

03

Receive treatment

If prescribed, medication is dispensed by a registered pharmacy and delivered securely.

04

Review and adjust

Your progress and side effects guide ongoing support and any appropriate dose changes.

Important medication information

Know what needs prompt action.

Common effects: nausea, vomiting, diarrhoea, constipation and stomach discomfort can occur, especially during dose changes.

Seek urgent help: severe, persistent abdominal pain that may spread to the back, with or without vomiting, can be a sign of pancreatitis.

Pregnancy: do not use these medicines while pregnant, trying to conceive or breastfeeding. Contact a clinician if pregnancy is suspected.

Surgery or sedation: tell the healthcare and anaesthetic team that you use a GLP-1 medicine before any procedure.

This is not a complete list of risks or side effects. Read the patient information leaflet supplied with your medicine and follow the advice of your prescriber and pharmacist.

Before you begin

Weight-management FAQs.

Prescription approval is never guaranteed. The eligibility assessment and clinician review determine whether the potential benefits outweigh the risks for you.

These medicines are generally licensed for adults living with obesity, or adults who are overweight and also have a weight-related health condition. BMI is only part of the assessment. Your medical history, current medicines and individual risks must also be reviewed before a prescription can be considered.

Start with an assessment

Find out whether treatment is suitable.

Contact our team to discuss the programme and the information needed for an initial clinical suitability review. Medication is only prescribed when clinically appropriate.